Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Query Builder

Query box

Help
Clear All

For additional assistance using the Custom Query please check out our Help Page

Filetype[PDF-6.13 MB]


Select the Download button to view the document
This document is over 5mb in size and cannot be previewed
  • English
    • Details You May Also Like

    Details:

    • Corporate Authors:
      National Center for Infectious Diseases (U.S.). Division of Vector-Borne Infectious Diseases. Bacterial Zoonoses Branch.
    • Description:
      Two items are presented in this issue of the Lyme Disease Surveillance Summary, an interim progress report on CDC funded Cooperative Agreements for research and education on Lyme disease, and the reprint of a recent article published in the MMWR on complications of treatment of suspected Lyme disease.

      The CDC Cooperative Agreements on Lyme disease are in the final year of a 3-year cycle. It is anticipated that Congress will consider appropriation of funds for a second cycle of Cooperative Agreements to begin in FY 94. If new funding is appropriated, CDC will make efforts to have a Request for Proposal (RFP) announcement published in the Federal Register by October 1993 so that awards can be made by April 1, 1994. The timing of the RFP announcement will be published in the Lyme Disease Surveillance Summary. CDC is pleased with the progress of Cooperative Agreement projects funded to date and looks forward to a continuation of this program.

      The study on adverse consequences of ceftriaxone treatment of suspected Lyme disease patients in New Jersey was initiated as a follow-up of a community-based study of Lyme disease in children conducted by CDC and the New Jersey Department of Health in Monmouth and Ocean Counties in June of 1992. The conclusions of that study highlighted the need to do studies of hospitalized patients, including a study of possible adverse consequences of intravenous antibiotic therapy.

    • Subjects:
    • Series:
      Lyme disease surveillance summary ; v. 4, no. 2
    • Document Type:
      Newsletter
    • Genre:
      Statistics
    • Place as Subject:
      United States
    • Collection(s):
    • Main Document Checksum:
    • Download URL:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov